Corporate News 19-Jul-19
Gufic BioSciences launches Botulinum Neurotoxin in India
Gufic BioSciences announced the launch of Botulinum Neurotoxin in India in collaboration with USA based Company Prime Bio, Inc., led by Dr. Bal Ram Singh.
The Company has received regulatory approval to manufacture and market Botulinum Neurotoxin.
Previous News
TCI Finance Ltd leads losers in 'B' group
( Hot Pursuit - 17-Aug-21 14:45 )
Gufic BioSciences to conduct board meeting
( Corporate News - 03-Feb-22 11:37 )
Gufic Biosciences enters into research and collaboration agreement with Australia based Selvax
( Corporate News - 09-Mar-22 18:34 )
Gufic BioSciences to conduct AGM
( Corporate News - 05-Sep-23 15:21 )
Board of Gufic BioSciences approves change in directorate
( Corporate News - 28-Jun-24 10:45 )
Gufic Bioscience receives CDSCO nod to manufacture and sale of Antifungal drug
( Hot Pursuit - 11-Apr-22 17:45 )
Gufic BioSciences standalone net profit rises 276.25% in the March 2018 quarter
( Results - Announcements 08-Jun-18 15:24 )
Gufic BioSciences reports standalone net profit of Rs 31.21 crore in the June 2021 quarter
( Results - Announcements 12-Aug-21 07:46 )
Gufic BioSciences to hold EGM
( Corporate News - 30-Apr-18 15:12 )
Gufic Biosciences scales record high after posting robust Q2 results
( Hot Pursuit - 15-Dec-17 11:30 )
Gufic BioSciences to table results
( Corporate News - 30-Jan-19 11:14 )
Other Stories
Vardhan Capital & Finance schedules AGM
06-Jul-24 17:34
Automotive Axles schedules AGM
06-Jul-24 17:34
Maruti Infrastructure to conduct AGM
06-Jul-24 17:34
Torrent Power schedules AGM
06-Jul-24 17:34
Raghav Productivity Enhancers to hold AGM
06-Jul-24 17:34
Berger Paints India schedules AGM
06-Jul-24 17:33
Walpar Nutritions to conduct AGM
06-Jul-24 17:33
Weizmann AGM scheduled
06-Jul-24 17:33
Gretex Industries schedules AGM
06-Jul-24 17:33
Karma Energy schedules AGM
06-Jul-24 17:33
Back
Top
